Simoens, Steven <br/><br/>
Biosimilars and market access: a question of comparability and costs?  [electronic resource] 

 -  Targeted oncology  Dec 2012 
 - 227-31 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1776-260X 
<br/><br/><label>Standard No.: </label>10.1007/s11523-011-0192-7  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Biosimilar Pharmaceuticals--therapeutic use<br/>Cost-Benefit Analysis<br/>Drug Discovery--legislation & jurisprudence<br/>Europe<br/>Health Care Sector<br/>Health Services Accessibility<br/>Humans<br/>United States